Truck drivers who fail to adhere to sleep apnea treatment have higher crash rate

March 21, 2016, Harvard T.H. Chan School of Public Health
Credit: Vera Kratochvil/public domain

Truck drivers with obstructive sleep apnea (OSA) who failed to adhere to treatment had a rate of preventable crashes five times higher than that of truckers without the ailment, according to researchers from Harvard T.H. Chan School of Public Health, University of Minnesota, Morris, Brigham and Women's Hospital (BWH) and colleagues.

The study—which looked at the results of the first large-scale employer program to screen, diagnose, and monitor OSA treatment adherence in the U.S. trucking industry—will be published online March 21, 2016 in the journal Sleep.

The findings suggest that commercial truck should be regularly screened for and required to treat it if they have it in order to continue driving, according to Stefanos Kales, associate professor in the Department of Environmental Health at Harvard Chan School, Chief of Occupational Medicine at Cambridge Health Alliance, and senior author of the study. "Mandating screening, diagnosis, and treatment would reduce large truck and bus accidents, and therefore deaths and injuries among the motoring public," he said.

"It's estimated that up to 20% of all large truck crashes are due to drowsy or fatigued driving, which would account for almost 9,000 fatalities and up to 220,000 serious injuries," Kales said. OSA—a disorder in which sleep is disrupted by repeated stops and starts of breathing —is the most common cause of excessive daytime sleepiness or fatigue, and has been linked with negative impacts on attention, working memory, vigilance, and executive functioning. People with OSA can be treated with a machine that delivers pressurized air, via a mask that fits over the nose, to keep the throat open during sleep and thus promote uninterrupted breathing.

Although commercial truck drivers undergo a biennial examination to determine their medical fitness to safely operate a vehicle, there are currently no mandatory standards for OSA screening or diagnosis, in part because there have been no large-scale studies evaluating the crash risk of commercial drivers diagnosed with OSA.

In the new study, researchers analyzed the results of an OSA screening, diagnosis, and treatment program that was implemented by a major North American trucking firm, beginning in April 2006. They compared a control group of 2,016 drivers unlikely to have OSA with a group of 1,613 drivers with OSA. Of the latter group, 682 fully adhered with requirements to use company-provided pressurized air machines, 571 partially adhered to the treatment, and 360 never adhered. For each group, the researchers also looked at data on serious preventable crashes in which the driver was found at fault.

They found that drivers with OSA who didn't adhere to treatment had a rate of preventable crashes five-fold greater than that of the control group which had similar driving experience. They also found that drivers with OSA who were fully compliant with the company-mandated treatment had a crash rate no different than that of the control group.

Kales noted that the U.S. Federal Motor Carrier Safety Administration is currently considering the possibility of mandating sleep apnea screening for truck drivers and requiring treatment for those with a positive diagnosis. "The regulations have been highly contested and debated for more than 10 years," he said. "This is a major issue and our findings may be the first in a decade to actually push the federal government to mandate sleep apnea screening for these drivers. In addition, the findings are also arguably generalizable to operators of airplanes, buses, ships, trains, and other modes of public transport."

"Given that the risk of heart disease, cancer, diabetes, dementia and premature death are similarly increased in people with untreated , regulatory agencies worldwide owe it to and to the motorists who share the road with them to require objective screening, diagnostic testing, and adherence monitoring for all commercial drivers," said co-author Charles A. Czeisler, chief of the Division of Sleep and Circadian Disorders at Brigham and Women's Hospital and Baldino Professor of Sleep Medicine at Harvard Medical School in Boston.

Explore further: Patients with PTSD together with sleep apnea may have reduced quality of life

More information: "Non-Adherence with Employer-Mandated Sleep Apnea Treatment and Increased Risk of Serious Truck Crashes," Sleep, March 21, 2016

Related Stories

Patients with PTSD together with sleep apnea may have reduced quality of life

February 8, 2016
New research finds patients suffering from posttraumatic stress disorder (PTSD) and obstructive sleep apnea (OSA) experienced lower quality of life, more sleepiness, and less adherence and response to positive airway pressure ...

Many patients with diagnosed OSA not receiving treatment

December 18, 2015
(HealthDay)—Many patients with diagnosed obstructive sleep apnea (OSA) are not being treated, with only 42 percent reporting adherence to positive airway pressure (PAP) treatment, according to research published in the ...

Trouble sleeping? The size of your tongue and tonsils could be why

March 8, 2016
The best time to identify signs of obstructive sleep apnea may not be at night while snoozing in bed but, instead, while sitting in the dentist's chair.

CPAP may not improve glycemic control in people with diabetes

March 11, 2016
People with type 2 diabetes and obstructive sleep apnea (OSA) may not experience improved glycemic control by using continuous positive airway pressure, or CPAP, as some studies have suggested, according to the results of ...

ATS publishes clinical practice guidelines on sleep apnea and driving

June 1, 2013
The American Thoracic Society has released new clinical practice guidelines on sleep apnea, sleepiness, and driving risk on non-commercial drivers.

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.